Peloton Wealth Strategists Precigen, Inc. Transaction History

Peloton Wealth Strategists

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $63,373 - $83,185	-12,700 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $12,480 - $16,440	-2,000 Reduced 13.61%	12,700 $83,000
Q1 2021 Jun 23, 2021	SELL	$6.74 - $10.95 $26,960 - $43,800	-4,000 Reduced 21.39%	14,700 $101,000
Q4 2020 Feb 17, 2021	SELL	$3.75 - $10.56 $11,250 - $31,680	-3,000 Reduced 13.82%	18,700 $191,000
Q3 2020 Nov 17, 2020	SELL	$3.5 - $6.2 $22,400 - $39,680	-6,400 Reduced 22.78%	21,700 $76,000
Q2 2020 Aug 13, 2020	SELL	$2.16 - $5.46 $3,240 - $8,190	-1,500 Reduced 5.07%	28,100 $140,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $43,216 - $212,824	29,600 New	29,600 $101,000

140

145M

292K

53.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $171M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Peloton Wealth Strategists, based on Form 13F filings with the SEC.

Stay updated on Peloton Wealth Strategists with notifications on news.